Imugene Limited Stock Price Prediction
| IUGNF Stock | USD 0.25 0.01 4.17% |
Momentum 40
Sell Extended
Oversold | Overbought |
Using Imugene hype-based prediction, you can estimate the value of Imugene Limited from the perspective of Imugene response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Imugene to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Imugene because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Imugene after-hype prediction price | USD 0.25 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Imugene |
Imugene After-Hype Price Prediction Density Analysis
As far as predicting the price of Imugene at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Imugene or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Imugene, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Imugene Estimiated After-Hype Price Volatility
In the context of predicting Imugene's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Imugene's historical news coverage. Imugene's after-hype downside and upside margins for the prediction period are 0.01 and 10.16, respectively. We have considered Imugene's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Imugene is out of control at this time. Analysis and calculation of next after-hype price of Imugene Limited is based on 3 months time horizon.
Imugene Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Imugene is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Imugene backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Imugene, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.67 | 9.91 | 0.00 | 0.43 | 0 Events / Month | 3 Events / Month | Uncertain |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.25 | 0.25 | 0.00 |
|
Imugene Hype Timeline
Imugene Limited is currently traded for 0.25. The entity stock is not elastic to its hype. The average elasticity to hype of competition is -0.43. Imugene is estimated not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is estimated to be very small, whereas the daily expected return is currently at 0.67%. %. The volatility of related hype on Imugene is about 1536.43%, with the expected price after the next announcement by competition of -0.18. About 15.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.0. Imugene Limited had not issued any dividends in recent years. The entity had 2:15 split on the 12th of November 2002. Assuming the 90 days horizon the next estimated press release will be uncertain. Check out Imugene Basic Forecasting Models to cross-verify your projections.Imugene Related Hype Analysis
Having access to credible news sources related to Imugene's direct competition is more important than ever and may enhance your ability to predict Imugene's future price movements. Getting to know how Imugene's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Imugene may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| PRNAF | Alterity Therapeutics Limited | (2.16) | 3 per month | 0.00 | 0.08 | 0.00 | 0.00 | 71.43 | |
| SPHRY | Starpharma Holdings | 0.00 | 0 per month | 2.64 | 0.09 | 8.33 | (6.25) | 33.24 | |
| MSCLF | Satellos Bioscience | (0.01) | 6 per month | 3.20 | 0.14 | 10.42 | (5.88) | 19.61 | |
| NICXF | Nicox SA | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| BSEM | Biostem Technologies | 0.00 | 0 per month | 5.45 | 0.08 | 17.65 | (9.69) | 39.49 | |
| POLBF | Poolbeg Pharma PLC | 0.09 | 8 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| VSBC | VitaSpring Biomedical Co | (2.16) | 13 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HSCHF | H Source Holdings | (2.16) | 7 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| KNTPF | Kintor Pharmaceutical Limited | (0.05) | 26 per month | 0.00 | 0.09 | 0.00 | 0.00 | 27.27 | |
| CLTEF | Calliditas Therapeutics AB | 0.00 | 0 per month | 0.00 | 0.17 | 28.95 | (38.33) | 58,082 |
Imugene Additional Predictive Modules
Most predictive techniques to examine Imugene price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Imugene using various technical indicators. When you analyze Imugene charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Imugene Predictive Indicators
The successful prediction of Imugene stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Imugene Limited, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Imugene based on analysis of Imugene hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Imugene's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Imugene's related companies.
Currently Active Assets on Macroaxis
Complementary Tools for Imugene Pink Sheet analysis
When running Imugene's price analysis, check to measure Imugene's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Imugene is operating at the current time. Most of Imugene's value examination focuses on studying past and present price action to predict the probability of Imugene's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Imugene's price. Additionally, you may evaluate how the addition of Imugene to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Transaction History View history of all your transactions and understand their impact on performance |